| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,794 |
6,986 |
$525K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,947 |
3,887 |
$403K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
7,687 |
2,911 |
$94K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
3,049 |
2,276 |
$93K |
| 86328 |
|
2,081 |
1,606 |
$58K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
581 |
547 |
$54K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,186 |
1,746 |
$27K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
866 |
638 |
$9K |
| 36415 |
Collection of venous blood by venipuncture |
1,513 |
1,360 |
$8K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
72 |
70 |
$5K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
15 |
13 |
$998.64 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
111 |
81 |
$785.21 |
| 92551 |
|
68 |
61 |
$456.37 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
96 |
80 |
$450.68 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
110 |
91 |
$196.94 |
| 90756 |
|
13 |
13 |
$194.22 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
26 |
26 |
$181.20 |
| 92587 |
|
25 |
21 |
$134.91 |
| 99173 |
|
80 |
70 |
$133.32 |
| 99406 |
|
12 |
12 |
$131.73 |
| 81003 |
|
14 |
14 |
$20.80 |